Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 143 entries
Sorted by: Best Match Show Resources per page
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy.

Cancers

Knebel FH, Barber LJ, Newey A, Kleftogiannis D, Woolston A, Griffiths B, Fenwick K, Bettoni F, Ribeiro MFSA, da Fonseca L, Costa F, Capareli FC, Hoff PM, Sabbaga J, Camargo AA, Gerlinger M.
PMID: 33322618
Cancers (Basel). 2020 Dec 11;12(12). doi: 10.3390/cancers12123736.

Epidermal growth factor receptor antibodies (EGFR-Abs) confer a survival benefit in patients with

Cite
Knebel FH, Barber LJ, Newey A, et al. Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers (Basel). 2020;12(12)doi: 10.3390/cancers12123736.
Knebel, F. H., Barber, L. J., Newey, A., Kleftogiannis, D., Woolston, A., Griffiths, B., Fenwick, K., Bettoni, F., Ribeiro, M. F. S. A., da Fonseca, L., Costa, F., Capareli, F. C., Hoff, P. M., Sabbaga, J., Camargo, A. A., & Gerlinger, M. (2020). Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers, 12(12), . https://doi.org/10.3390/cancers12123736
Knebel, Franciele H, et al. "Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy." Cancers vol. 12,12 (2020). doi: https://doi.org/10.3390/cancers12123736
Knebel FH, Barber LJ, Newey A, Kleftogiannis D, Woolston A, Griffiths B, Fenwick K, Bettoni F, Ribeiro MFSA, da Fonseca L, Costa F, Capareli FC, Hoff PM, Sabbaga J, Camargo AA, Gerlinger M. Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers (Basel). 2020 Dec 11;12(12). doi: 10.3390/cancers12123736. PMID: 33322618; PMCID: PMC7764102.
Copy Download .nbib Format: NLM
An unusual case of a penetrating neck injury (PNI) illustrating the use of a "no zone" approach for the management of this injury and a review of the literature.

Trauma case reports

Joseph AP, Newey A, Glover A, Mohabbat W.
PMID: 33644288
Trauma Case Rep. 2021 Feb 09;32:100402. doi: 10.1016/j.tcr.2021.100402. eCollection 2021 Apr.

We present an unusual case of a young male with a penetrating neck injury (PNI) due to a work-related injury. A metallic foreign body traversed from entry at surgical Zone 2 to Zone 1 in the neck and resulted...

Cite
Joseph AP, Newey A, Glover A, et al. An unusual case of a penetrating neck injury (PNI) illustrating the use of a "no zone" approach for the management of this injury and a review of the literature. Trauma Case Rep. 2021;32:100402doi: 10.1016/j.tcr.2021.100402.
Joseph, A. P., Newey, A., Glover, A., & Mohabbat, W. (2021). An unusual case of a penetrating neck injury (PNI) illustrating the use of a "no zone" approach for the management of this injury and a review of the literature. Trauma case reports, 32100402. https://doi.org/10.1016/j.tcr.2021.100402
Joseph, A P, et al. "An unusual case of a penetrating neck injury (PNI) illustrating the use of a "no zone" approach for the management of this injury and a review of the literature." Trauma case reports vol. 32 (2021): 100402. doi: https://doi.org/10.1016/j.tcr.2021.100402
Joseph AP, Newey A, Glover A, Mohabbat W. An unusual case of a penetrating neck injury (PNI) illustrating the use of a "no zone" approach for the management of this injury and a review of the literature. Trauma Case Rep. 2021 Feb 09;32:100402. doi: 10.1016/j.tcr.2021.100402. eCollection 2021 Apr. PMID: 33644288; PMCID: PMC7892993.
Copy Download .nbib Format: NLM
Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus.

Oxford medical case reports

Chinthapalli K, Newey A, Krause M.
PMID: 26421160
Oxf Med Case Reports. 2015 Sep 10;2015(9):320-2. doi: 10.1093/omcr/omv051. eCollection 2015 Sep.

We present an 89-year-old man with new onset of left-sided hemiballismus affecting his face, arm and leg. He was found to have hyperglycaemia with a glucose level of 20.2 mmol/l and had started prednisolone 3 months earlier for polymyalgia...

Cite
Chinthapalli K, Newey A, Krause M. Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus. Oxf Med Case Reports. 2015;2015(9):320-2doi: 10.1093/omcr/omv051.
Chinthapalli, K., Newey, A., & Krause, M. (2015). Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus. Oxford medical case reports, 2015(9), 320-2. https://doi.org/10.1093/omcr/omv051
Chinthapalli, Krishna, et al. "Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus." Oxford medical case reports vol. 2015,9 (2015): 320-2. doi: https://doi.org/10.1093/omcr/omv051
Chinthapalli K, Newey A, Krause M. Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus. Oxf Med Case Reports. 2015 Sep 10;2015(9):320-2. doi: 10.1093/omcr/omv051. eCollection 2015 Sep. PMID: 26421160; PMCID: PMC4584621.
Copy Download .nbib Format: NLM
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.

The British journal of dermatology

Schaller M, Almeida LMC, Bewley A, Cribier B, Del Rosso J, Dlova NC, Gallo RL, Granstein RD, Kautz G, Mannis MJ, Micali G, Oon HH, Rajagopalan M, Steinhoff M, Tanghetti E, Thiboutot D, Troielli P, Webster G, Zierhut M, van Zuuren EJ, Tan J.
PMID: 31392722
Br J Dermatol. 2020 May;182(5):1269-1276. doi: 10.1111/bjd.18420. Epub 2019 Oct 16.

BACKGROUND: A transition from a subtyping to a phenotyping approach in rosacea is underway, allowing individual patient management according to presenting features instead of categorization by predefined subtypes. The ROSacea COnsensus (ROSCO) 2017 recommendations further support this transition and...

Cite
Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2019;182(5):1269-1276doi: 10.1111/bjd.18420.
Schaller, M., Almeida, L. M. C., Bewley, A., Cribier, B., Del Rosso, J., Dlova, N. C., Gallo, R. L., Granstein, R. D., Kautz, G., Mannis, M. J., Micali, G., Oon, H. H., Rajagopalan, M., Steinhoff, M., Tanghetti, E., Thiboutot, D., Troielli, P., Webster, G., Zierhut, M., van Zuuren, E. J., & Tan, J. (2020). Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. The British journal of dermatology, 182(5), 1269-1276. https://doi.org/10.1111/bjd.18420
Schaller, M, et al. "Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel." The British journal of dermatology vol. 182,5 (2020): 1269-1276. doi: https://doi.org/10.1111/bjd.18420
Schaller M, Almeida LMC, Bewley A, Cribier B, Del Rosso J, Dlova NC, Gallo RL, Granstein RD, Kautz G, Mannis MJ, Micali G, Oon HH, Rajagopalan M, Steinhoff M, Tanghetti E, Thiboutot D, Troielli P, Webster G, Zierhut M, van Zuuren EJ, Tan J. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020 May;182(5):1269-1276. doi: 10.1111/bjd.18420. Epub 2019 Oct 16. PMID: 31392722; PMCID: PMC7317217.
Copy Download .nbib Format: NLM
Biologics in dermatology.

Pharmaceuticals (Basel, Switzerland)

Chandler D, Bewley A.
PMID: 24276125
Pharmaceuticals (Basel). 2013 Apr 17;6(4):557-78. doi: 10.3390/ph6040557.

Skin and subcutaneous diseases affect millions of people worldwide, causing significant morbidity. Biologics are becoming increasingly useful for the treatment of many skin diseases, particularly as alternatives for patients who have failed to tolerate or respond to conventional systemic...

Cite
Chandler D, Bewley A. Biologics in dermatology. Pharmaceuticals (Basel). 2013;6(4):557-78doi: 10.3390/ph6040557.
Chandler, D., & Bewley, A. (2013). Biologics in dermatology. Pharmaceuticals (Basel, Switzerland), 6(4), 557-78. https://doi.org/10.3390/ph6040557
Chandler, David, and Bewley, Anthony. "Biologics in dermatology." Pharmaceuticals (Basel, Switzerland) vol. 6,4 (2013): 557-78. doi: https://doi.org/10.3390/ph6040557
Chandler D, Bewley A. Biologics in dermatology. Pharmaceuticals (Basel). 2013 Apr 17;6(4):557-78. doi: 10.3390/ph6040557. PMID: 24276125; PMCID: PMC3816698.
Copy Download .nbib Format: NLM
Patients with nodular prurigo commonly have pre-existing psychological disease that requires treatment concomitant with cutaneous therapies.

The British journal of dermatology

Pathmarajah P, Gkini MA, Fox H, Muralidharan V, Taylor RE, Bewley A.
PMID: 34227098
Br J Dermatol. 2021 Dec;185(6):1258-1259. doi: 10.1111/bjd.20627. Epub 2021 Sep 26.

No abstract available.

Cite
Pathmarajah P, Gkini MA, Fox H, et al. Patients with nodular prurigo commonly have pre-existing psychological disease that requires treatment concomitant with cutaneous therapies. Br J Dermatol. 2021;185(6):1258-1259doi: 10.1111/bjd.20627.
Pathmarajah, P., Gkini, M. A., Fox, H., Muralidharan, V., Taylor, R. E., & Bewley, A. (2021). Patients with nodular prurigo commonly have pre-existing psychological disease that requires treatment concomitant with cutaneous therapies. The British journal of dermatology, 185(6), 1258-1259. https://doi.org/10.1111/bjd.20627
Pathmarajah, P, et al. "Patients with nodular prurigo commonly have pre-existing psychological disease that requires treatment concomitant with cutaneous therapies." The British journal of dermatology vol. 185,6 (2021): 1258-1259. doi: https://doi.org/10.1111/bjd.20627
Pathmarajah P, Gkini MA, Fox H, Muralidharan V, Taylor RE, Bewley A. Patients with nodular prurigo commonly have pre-existing psychological disease that requires treatment concomitant with cutaneous therapies. Br J Dermatol. 2021 Dec;185(6):1258-1259. doi: 10.1111/bjd.20627. Epub 2021 Sep 26. PMID: 34227098.
Copy Download .nbib Format: NLM
Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study).

The British journal of dermatology

Burden-Teh E, Murphy R, Gran S, Nijsten T, Hughes C, Abdul-Wahab A, Bewley A, Burrows N, Darne S, Gach JE, Katugampola R, Jury CS, Kuet K, Llewellyn J, McPherson T, Ravenscroft JC, Taibjee S, Wilkinson C, Thomas KS.
PMID: 34477218
Br J Dermatol. 2021 Sep 03; doi: 10.1111/bjd.20689. Epub 2021 Sep 03.

BACKGROUND: In children, psoriasis can be challenging to diagnose. Difficulties arise from differences in the clinical presentation compared with adults.OBJECTIVES: To test the diagnostic accuracy of previously agreed consensus criteria and to develop a shortlist of the best predictive...

Cite
Burden-Teh E, Murphy R, Gran S, et al. Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study). Br J Dermatol. 2021;doi: 10.1111/bjd.20689.
Burden-Teh, E., Murphy, R., Gran, S., Nijsten, T., Hughes, C., Abdul-Wahab, A., Bewley, A., Burrows, N., Darne, S., Gach, J. E., Katugampola, R., Jury, C. S., Kuet, K., Llewellyn, J., McPherson, T., Ravenscroft, J. C., Taibjee, S., Wilkinson, C., & Thomas, K. S. (2021). Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study). The British journal of dermatology, . https://doi.org/10.1111/bjd.20689
Burden-Teh, E, et al. "Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study)." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20689
Burden-Teh E, Murphy R, Gran S, Nijsten T, Hughes C, Abdul-Wahab A, Bewley A, Burrows N, Darne S, Gach JE, Katugampola R, Jury CS, Kuet K, Llewellyn J, McPherson T, Ravenscroft JC, Taibjee S, Wilkinson C, Thomas KS. Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study). Br J Dermatol. 2021 Sep 03; doi: 10.1111/bjd.20689. Epub 2021 Sep 03. PMID: 34477218.
Copy Download .nbib Format: NLM
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes.

Journal of the European Academy of Dermatology and Venereology : JEADV

Finlay AY, Chernyshov PV, Tomas Aragones L, Bewley A, Svensson A, Manolache L, Marron S, Suru A, Sampogna F, Salek MS, Poot F.
PMID: 33094518
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):318-328. doi: 10.1111/jdv.16914. Epub 2020 Oct 23.

The pharmaceutical approach to skin disease has been hugely successful, but despite effective drugs being available and used, there are still vast numbers of people who continue to have some level of persisting skin disease and continue to experience...

Cite
Finlay AY, Chernyshov PV, Tomas Aragones L, et al. Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2020;35(2):318-328doi: 10.1111/jdv.16914.
Finlay, A. Y., Chernyshov, P. V., Tomas Aragones, L., Bewley, A., Svensson, A., Manolache, L., Marron, S., Suru, A., Sampogna, F., Salek, M. S., & Poot, F. (2021). Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(2), 318-328. https://doi.org/10.1111/jdv.16914
Finlay, A Y, et al. "Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes." Journal of the European Academy of Dermatology and Venereology : JEADV vol. 35,2 (2021): 318-328. doi: https://doi.org/10.1111/jdv.16914
Finlay AY, Chernyshov PV, Tomas Aragones L, Bewley A, Svensson A, Manolache L, Marron S, Suru A, Sampogna F, Salek MS, Poot F. Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):318-328. doi: 10.1111/jdv.16914. Epub 2020 Oct 23. PMID: 33094518.
Copy Download .nbib Format: NLM
Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.

Nature communications

Chatterjee J, Sanapala S, Cobb O, Bewley A, Goldstein AK, Cordell E, Ge X, Garbow JR, Holtzman MJ, Gutmann DH.
PMID: 34880260
Nat Commun. 2021 Dec 08;12(1):7122. doi: 10.1038/s41467-021-27455-6.

To elucidate the mechanisms underlying the reduced incidence of brain tumors in children with Neurofibromatosis type 1 (NF1) and asthma, we leverage Nf1 optic pathway glioma (Nf1

Cite
Chatterjee J, Sanapala S, Cobb O, et al. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia. Nat Commun. 2021;12(1):7122doi: 10.1038/s41467-021-27455-6.
Chatterjee, J., Sanapala, S., Cobb, O., Bewley, A., Goldstein, A. K., Cordell, E., Ge, X., Garbow, J. R., Holtzman, M. J., & Gutmann, D. H. (2021). Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia. Nature communications, 12(1), 7122. https://doi.org/10.1038/s41467-021-27455-6
Chatterjee, Jit, et al. "Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia." Nature communications vol. 12,1 (2021): 7122. doi: https://doi.org/10.1038/s41467-021-27455-6
Chatterjee J, Sanapala S, Cobb O, Bewley A, Goldstein AK, Cordell E, Ge X, Garbow JR, Holtzman MJ, Gutmann DH. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia. Nat Commun. 2021 Dec 08;12(1):7122. doi: 10.1038/s41467-021-27455-6. PMID: 34880260.
Copy Download .nbib Format: NLM
Exploring patient-physician trust dynamics in patients with psychocutaneous and general dermatological disease.

The British journal of dermatology

Stavrou PZ, Gkini MA, Taylor R, Bewley A.
PMID: 33084024
Br J Dermatol. 2021 Mar;184(3):568-570. doi: 10.1111/bjd.19622. Epub 2020 Dec 15.

No abstract available.

Cite
Stavrou PZ, Gkini MA, Taylor R, et al. Exploring patient-physician trust dynamics in patients with psychocutaneous and general dermatological disease. Br J Dermatol. 2020;184(3):568-570doi: 10.1111/bjd.19622.
Stavrou, P. Z., Gkini, M. A., Taylor, R., & Bewley, A. (2021). Exploring patient-physician trust dynamics in patients with psychocutaneous and general dermatological disease. The British journal of dermatology, 184(3), 568-570. https://doi.org/10.1111/bjd.19622
Stavrou, P-Z, et al. "Exploring patient-physician trust dynamics in patients with psychocutaneous and general dermatological disease." The British journal of dermatology vol. 184,3 (2021): 568-570. doi: https://doi.org/10.1111/bjd.19622
Stavrou PZ, Gkini MA, Taylor R, Bewley A. Exploring patient-physician trust dynamics in patients with psychocutaneous and general dermatological disease. Br J Dermatol. 2021 Mar;184(3):568-570. doi: 10.1111/bjd.19622. Epub 2020 Dec 15. PMID: 33084024.
Copy Download .nbib Format: NLM
Assessment of holographic microscopy for quantifying marine particle size and concentration.

Limnology and oceanography, methods

Walcutt NL, Knörlein B, Cetinić I, Ljubesic Z, Bosak S, Sgouros T, Montalbano AL, Neeley A, Menden-Deuer S, Omand MM.
PMID: 33041697
Limnol Oceanogr Methods. 2020 Sep;18(9):516-530. doi: 10.1002/lom3.10379. Epub 2020 Aug 05.

Holographic microscopy has emerged as a tool for in situ imaging of microscopic organisms and other particles in the marine environment: appealing because of the relatively larger sampling volume and simpler optical configuration compared to other imaging systems. However,...

Cite
Walcutt NL, Knörlein B, Cetinić I, et al. Assessment of holographic microscopy for quantifying marine particle size and concentration. Limnol Oceanogr Methods. 2020;18(9):516-530doi: 10.1002/lom3.10379.
Walcutt, N. L., Knörlein, B., Cetinić, I., Ljubesic, Z., Bosak, S., Sgouros, T., Montalbano, A. L., Neeley, A., Menden-Deuer, S., & Omand, M. M. (2020). Assessment of holographic microscopy for quantifying marine particle size and concentration. Limnology and oceanography, methods, 18(9), 516-530. https://doi.org/10.1002/lom3.10379
Walcutt, Noah L, et al. "Assessment of holographic microscopy for quantifying marine particle size and concentration." Limnology and oceanography, methods vol. 18,9 (2020): 516-530. doi: https://doi.org/10.1002/lom3.10379
Walcutt NL, Knörlein B, Cetinić I, Ljubesic Z, Bosak S, Sgouros T, Montalbano AL, Neeley A, Menden-Deuer S, Omand MM. Assessment of holographic microscopy for quantifying marine particle size and concentration. Limnol Oceanogr Methods. 2020 Sep;18(9):516-530. doi: 10.1002/lom3.10379. Epub 2020 Aug 05. PMID: 33041697; PMCID: PMC7540046.
Copy Download .nbib Format: NLM
Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis.

Dermatology and therapy

Bewley A, Fowler J, Schöfer H, Kerrouche N, Rives V.
PMID: 27025711
Dermatol Ther (Heidelb). 2016 Jun;6(2):249. doi: 10.1007/s13555-016-0111-z.

No abstract available.

Cite
Bewley A, Fowler J, Schöfer H, et al. Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis. Dermatol Ther (Heidelb). 2016;6(2):249doi: 10.1007/s13555-016-0111-z.
Bewley, A., Fowler, J., Schöfer, H., Kerrouche, N., & Rives, V. (2016). Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis. Dermatology and therapy, 6(2), 249. https://doi.org/10.1007/s13555-016-0111-z
Bewley, Anthony, et al. "Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis." Dermatology and therapy vol. 6,2 (2016): 249. doi: https://doi.org/10.1007/s13555-016-0111-z
Bewley A, Fowler J, Schöfer H, Kerrouche N, Rives V. Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis. Dermatol Ther (Heidelb). 2016 Jun;6(2):249. doi: 10.1007/s13555-016-0111-z. PMID: 27025711; PMCID: PMC4906105.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 143 entries